3-aryl-4H-chromene-4-ones as antineoplastic agents for the treatment of cancer
Abstract:
Isoflavonoids or pharmaceutically acceptable salts thereof or pharmaceutically acceptable compositions thereof for the treatment of prostate cancer or for the treatment or inhibition of prostate cancer metastasis in a patient in need thereof are disclosed.
Information query
Patent Agency Ranking
0/0